Skip to main content

Professor David MacEwan
BSc (Hons), PhD, FRSB, FBPhS, SFHEA

Research

Research Interests

See

http://www.researchgate.net/profile/David_MacEwan/

http://www.researcherid.com/rid/F-7044-2011

Current Research Group

Postdocs
Dr Rebecca Dawson
Dr Nicholas Harper
Dr Andrea Linford
Dr Adam Linley
Dr Vanessa Marensi

Postgrads (Primary Supervisor)
Mr Taha Alqahtani
Ms Sujitra Keadsanti
Ms Melanie Maerken
Mr Jonathan Po
Mr Simeon Ramsey
Ms Amy Robinson
Mr Niraj Shah

Postgrads (Secondary Supervision)
Mr Naif Alhumeed
Dr Eve Smith

Research grants

Research Support Fees for Rehab Nawaf Shayem Alanazi

ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)

March 2020 - February 2021

Kinomic reprogramming during clonal evolution and therapy resistance in chronic lymphocytic leukaemia

LEUKA (UK)

September 2018 - December 2020

Kinome profiling and mass cytometry as tools to detect rewiring of B cell receptor signalling in the malignant cells of chronic lymphocytic leukaemia patients taking ibrutinib

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

March 2019 - September 2022

Bench Fees - Taha Yahya T Alqahtani

ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)

April 2017 - March 2020

Reversal of FLT3-ITD mutations in acute myeloid leukaemia and its effect on chemotherapy resistance

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

April 2017 - January 2021

Characterising the Bruton's kinase signaling nexus in leukaemia

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

September 2015 - September 2018

Determining ibrutinib's potential to treat human leukaemias - novel uses for an exciting new Bruton's tyrosine kinase (TTK) inhibitor

NORTH WEST CANCER RESEARCH FUND

September 2014 - June 2021